| TH1L involvement in colorectal cancer pathogenesis by regulation of CCL20 through the NF-kappaB signalling pathway. | TH1L involvement in colorectal cancer pathogenesis by regulation of CCL20 through the NF-κB signalling pathway.
Wang S, Sun Y, Li C, Chong Y, Ai M, Wang Y, Shi H, Shang Y., Free PMC Article | 06/5/2024 |
| VDR promotes pancreatic cancer progression in vivo by activating CCL20-mediated M2 polarization of tumor associated macrophage. | VDR promotes pancreatic cancer progression in vivo by activating CCL20-mediated M2 polarization of tumor associated macrophage.
Li H, Ruan Y, Liu C, Fan X, Yao Y, Dai Y, Song Y, Jiang D, Sun N, Jiao G, Chen Z, Fan S, Meng F, Yang H, Zhang Y, Li Z., Free PMC Article | 04/18/2024 |
| Food protein-induced allergic proctocolitis in infants is associated with low serum levels of macrophage inflammatory protein-3a. | Food protein-induced allergic proctocolitis in infants is associated with low serum levels of macrophage inflammatory protein-3a.
Koksal BT, Barıs Z, Sencelikel T, Ozcay F, Ozbek OY. | 03/4/2024 |
| Role of the CCL20/CCR6 axis in tubular epithelial cell injury: Kidney-specific translational insights from acute kidney injury to chronic kidney disease. | Role of the CCL20/CCR6 axis in tubular epithelial cell injury: Kidney-specific translational insights from acute kidney injury to chronic kidney disease.
Yoo KD, Yu MY, Kim KH, Lee S, Park E, Kang S, Lim DH, Lee Y, Song J, Kown S, Kim YC, Kim DK, Lee JS, Kim YS, Yang SH. | 01/11/2024 |
| Transcription Factor TCF3 Promotes Macrophage-Mediated Inflammation and MMP Secretion in Abdominal Aortic Aneurysm by Regulating miR-143-5p /CCL20. | Transcription Factor TCF3 Promotes Macrophage-Mediated Inflammation and MMP Secretion in Abdominal Aortic Aneurysm by Regulating miR-143-5p /CCL20.
Li Y, Li R, Li Y, Li G, Zhao Y, Mou H, Chen Y, Xiao L, Gong K., Free PMC Article | 12/15/2023 |
| CCL20 inhibition for treating inflammation in ankylosing spondylitis. | CCL20 inhibition for treating inflammation in ankylosing spondylitis.
Won EJ, Kim HJ, Lee YJ, Kim MJ, Lee HI, Jang HH, Kim SH, Kang JH, Park KJ, Shim SC, Jo S, Kim TH, Kim TJ. | 12/5/2023 |
| Saturated Fat-Mediated Upregulation of IL-32 and CCL20 in Hepatocytes Contributes to Higher Expression of These Fibrosis-Driving Molecules in MASLD. | Saturated Fat-Mediated Upregulation of IL-32 and CCL20 in Hepatocytes Contributes to Higher Expression of These Fibrosis-Driving Molecules in MASLD.
Schilcher K, Dayoub R, Kubitza M, Riepl J, Klein K, Buechler C, Melter M, Weiss TS., Free PMC Article | 09/14/2023 |
| CCL20 is a potential therapeutic target associated with immune infiltration in breast cancer. | CCL20 is a potential therapeutic target associated with immune infiltration in breast cancer.
Zhai H, Zhang N, Mo D, Qin T., Free PMC Article | 08/14/2023 |
| CC chemokine ligand 20 (CCL20) positively regulates collagen type I production in 3D skin equivalent tissues. | CC chemokine ligand 20 (CCL20) positively regulates collagen type I production in 3D skin equivalent tissues.
Bandow K, Smith A, Watkins T, Shenk S, Gerami-Naini B, Garlick JA. | 04/5/2023 |
| Plasma Olink Proteomics Identifies CCL20 as a Novel Predictive and Diagnostic Inflammatory Marker for Preeclampsia. | Plasma Olink Proteomics Identifies CCL20 as a Novel Predictive and Diagnostic Inflammatory Marker for Preeclampsia.
Wang X, Yip KC, He A, Tang J, Liu S, Yan R, Zhang Q, Li R., Free PMC Article | 12/10/2022 |
| SMAD4 Suppresses Colitis-associated Carcinoma Through Inhibition of CCL20/CCR6-mediated Inflammation. | SMAD4 Suppresses Colitis-associated Carcinoma Through Inhibition of CCL20/CCR6-mediated Inflammation.
Hanna DN, Smith PM, Novitskiy SV, Washington MK, Zi J, Weaver CJ, Hamaamen JA, Lewis KB, Zhu J, Yang J, Liu Q, Beauchamp RD, Means AL., Free PMC Article | 10/29/2022 |
| Clinical and Prognostic Value of PPIA, SQSTM1, and CCL20 in Hepatocellular Carcinoma Patients by Single-Cell Transcriptome Analysis. | Clinical and Prognostic Value of PPIA, SQSTM1, and CCL20 in Hepatocellular Carcinoma Patients by Single-Cell Transcriptome Analysis.
Mou L, Jia C, Wu Z, Xin B, Liang Zhen CA, Wang B, Ni Y, Pu Z., Free PMC Article | 10/22/2022 |
| Tumor Necrosis Factor-alpha-Induced C-C Motif Chemokine Ligand 20 Expression through TNF Receptor 1-Dependent Activation of EGFR/p38 MAPK and JNK1/2/FoxO1 or the NF-kappaB Pathway in Human Cardiac Fibroblasts. | Tumor Necrosis Factor-α-Induced C-C Motif Chemokine Ligand 20 Expression through TNF Receptor 1-Dependent Activation of EGFR/p38 MAPK and JNK1/2/FoxO1 or the NF-κB Pathway in Human Cardiac Fibroblasts.
Yang CM, Yang CC, Hsu WH, Hsiao LD, Tseng HC, Shih YF., Free PMC Article | 09/3/2022 |
| CCL20 promotes lung adenocarcinoma progression by driving epithelial-mesenchymal transition. | CCL20 promotes lung adenocarcinoma progression by driving epithelial-mesenchymal transition.
Fan T, Li S, Xiao C, Tian H, Zheng Y, Liu Y, Li C, He J., Free PMC Article | 07/30/2022 |
| Streptococcus gordonii-Induced miRNAs Regulate CCL20 Responses in Human Oral Epithelial Cells. | Streptococcus gordonii-Induced miRNAs Regulate CCL20 Responses in Human Oral Epithelial Cells.
Tubero Euzebio Alves V, Al-Attar A, Alimova Y, Maynard MH, Kirakodu S, Martinez-Porras A, Hawk GS, Ebersole JL, Stamm S, Gonzalez OA., Free PMC Article | 04/30/2022 |
| Multifaceted roles of CCL20 (C-C motif chemokine ligand 20): mechanisms and communication networks in breast cancer progression. | Multifaceted roles of CCL20 (C-C motif chemokine ligand 20): mechanisms and communication networks in breast cancer progression.
Kwantwi LB, Wang S, Sheng Y, Wu Q., Free PMC Article | 02/26/2022 |
| NR4A3 and CCL20 clusters dominate the genetic networks in CD146(+) blood cells during acute myocardial infarction in humans. | NR4A3 and CCL20 clusters dominate the genetic networks in CD146(+) blood cells during acute myocardial infarction in humans.
Wang YH, Li CX, Stephenson JM, Marrelli SP, Kou YM, Meng DZ, Wu T., Free PMC Article | 02/5/2022 |
| PERK signaling through C/EBPdelta contributes to ER stress-induced expression of immunomodulatory and tumor promoting chemokines by cancer cells. | PERK signaling through C/EBPδ contributes to ER stress-induced expression of immunomodulatory and tumor promoting chemokines by cancer cells.
Sheshadri N, Poria DK, Sharan S, Hu Y, Yan C, Koparde VN, Balamurugan K, Sterneck E., Free PMC Article | 02/5/2022 |
| Fusobacterium nucleatum promotes colorectal cancer metastasis through miR-1322/CCL20 axis and M2 polarization. | Fusobacterium nucleatum promotes colorectal cancer metastasis through miR-1322/CCL20 axis and M2 polarization.
Xu C, Fan L, Lin Y, Shen W, Qi Y, Zhang Y, Chen Z, Wang L, Long Y, Hou T, Si J, Chen S., Free PMC Article | 01/29/2022 |
| Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment. | Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment.
Kfoury Y, Baryawno N, Severe N, Mei S, Gustafsson K, Hirz T, Brouse T, Scadden EW, Igolkina AA, Kokkaliaris K, Choi BD, Barkas N, Randolph MA, Shin JH, Saylor PJ, Scadden DT, Sykes DB, Kharchenko PV, as part of the Boston Bone Metastases Consortium., Free PMC Article | 01/8/2022 |
| Increased plasma levels of CCL20 in peripheral blood of rheumatoid arthritis patients and its association with clinical and laboratory parameters. | Increased plasma levels of CCL20 in peripheral blood of rheumatoid arthritis patients and its association with clinical and laboratory parameters.
Pournazari M, Feizollahi P, Roghani SA, Assar S, Soufivand P, Soleymani B, Bahrehmand F, Kish ZM, Taghadosi M. | 01/8/2022 |
| Amino terminal recognition by a CCR6 chemokine receptor antibody blocks CCL20 signaling and IL-17 expression via beta-arrestin. | Amino terminal recognition by a CCR6 chemokine receptor antibody blocks CCL20 signaling and IL-17 expression via β-arrestin.
Gómez-Melero S, García-Maceira FI, García-Maceira T, Luna-Guerrero V, Montero-Peñalvo G, Túnez-Fiñana I, Paz-Rojas E., Free PMC Article | 01/1/2022 |
| Common and disorder-specific upregulation of the inflammatory markers TRAIL and CCL20 in depression and schizophrenia. | Common and disorder-specific upregulation of the inflammatory markers TRAIL and CCL20 in depression and schizophrenia.
Klaus F, Guetter K, Schlegel R, Spiller TR, Seifritz E, Cathomas F, Kaiser S., Free PMC Article | 01/1/2022 |
| Tumor-associated neutrophils activated by tumor-derived CCL20 (C-C motif chemokine ligand 20) promote T cell immunosuppression via programmed death-ligand 1 (PD-L1) in breast cancer. | Tumor-associated neutrophils activated by tumor-derived CCL20 (C-C motif chemokine ligand 20) promote T cell immunosuppression via programmed death-ligand 1 (PD-L1) in breast cancer.
Kwantwi LB, Wang S, Zhang W, Peng W, Cai Z, Sheng Y, Xiao H, Wang X, Wu Q., Free PMC Article | 01/1/2022 |
| Chemokine CCL20 promotes the paclitaxel resistance of CD44(+)CD117(+) cells via the Notch1 signaling pathway in ovarian cancer. | Chemokine CCL20 promotes the paclitaxel resistance of CD44(+)CD117(+) cells via the Notch1 signaling pathway in ovarian cancer.
Chen M, Su J, Feng C, Liu Y, Zhao L, Tian Y., Free PMC Article | 12/18/2021 |